115 related articles for article (PubMed ID: 28341402)
21. PET imaging of demyelination and remyelination in the cuprizone mouse model for multiple sclerosis: a comparison between [11C]CIC and [11C]MeDAS.
de Paula Faria D; de Vries EF; Sijbesma JW; Dierckx RA; Buchpiguel CA; Copray S
Neuroimage; 2014 Feb; 87():395-402. PubMed ID: 24188813
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and screening of a haloacetamidine containing library to identify PAD4 selective inhibitors.
Jones JE; Slack JL; Fang P; Zhang X; Subramanian V; Causey CP; Coonrod SA; Guo M; Thompson PR
ACS Chem Biol; 2012 Jan; 7(1):160-5. PubMed ID: 22004374
[TBL] [Abstract][Full Text] [Related]
23. Tropisetron diminishes demyelination and disease severity in an animal model of multiple sclerosis.
Aminian A; Noorbakhsh F; Ghazi-Khansari M; Kafami L; Javadi S; Hassanzadeh G; Rahimian R; Dehpour AR; Mehr SE
Neuroscience; 2013 Sep; 248():299-306. PubMed ID: 23774631
[TBL] [Abstract][Full Text] [Related]
24. Distribution of oligodendrocyte loss and mitochondrial toxicity in the cuprizone-induced experimental demyelination model.
Acs P; Selak MA; Komoly S; Kalman B
J Neuroimmunol; 2013 Sep; 262(1-2):128-31. PubMed ID: 23890807
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of the stress-associated gene p8 in mouse models of demyelination and in multiple sclerosis tissues.
Plant SR; Wang Y; Vasseur S; Thrash JC; McMahon EJ; Bergstralh DT; Arnett HA; Miller SD; Carson MJ; Iovanna JL; Ting JP
Glia; 2006 Apr; 53(5):529-37. PubMed ID: 16374777
[TBL] [Abstract][Full Text] [Related]
26. Cuprizone Model as a Tool for Preclinical Studies of the Efficacy of Multiple Sclerosis Diagnosis and Therapy.
Abakumova TO; Kuz'kina AA; Zharova ME; Pozdeeva DA; Gubskii IL; Shepeleva II; Antonova OM; Nukolova NV; Kekelidze ZI; Chekhonin VP
Bull Exp Biol Med; 2015 May; 159(1):111-5. PubMed ID: 26028235
[TBL] [Abstract][Full Text] [Related]
27. Biological relevance of citrullinations: diagnostic, prognostic and therapeutic options.
Gudmann NS; Hansen NU; Jensen AC; Karsdal MA; Siebuhr AS
Autoimmunity; 2015 Mar; 48(2):73-9. PubMed ID: 25520183
[TBL] [Abstract][Full Text] [Related]
28. Experimental demyelination caused by primary oligodendrocyte dystrophy. Regional distribution of the lesions in the nervous system of mice [corrected].
Komoly S
Ideggyogy Sz; 2005 Jan; 58(1-2):40-3. PubMed ID: 15884397
[TBL] [Abstract][Full Text] [Related]
29. Interrogation of the Active Sites of Protein Arginine Deiminases (PAD1, -2, and -4) Using Designer Probes.
Bello AM; Wasilewski E; Wei L; Moscarello MA; Kotra LP
ACS Med Chem Lett; 2013 Feb; 4(2):249-53. PubMed ID: 24900657
[TBL] [Abstract][Full Text] [Related]
30. Photochemical Control of Protein Arginine Deiminase (PAD) Activity.
Mondal S; Parelkar SS; Nagar M; Thompson PR
ACS Chem Biol; 2018 Apr; 13(4):1057-1065. PubMed ID: 29517899
[TBL] [Abstract][Full Text] [Related]
31. Acid sphingomyelinase deficiency enhances myelin repair after acute and chronic demyelination.
Chami M; Halmer R; Schnoeder L; Anne Becker K; Meier C; Fassbender K; Gulbins E; Walter S
PLoS One; 2017; 12(6):e0178622. PubMed ID: 28582448
[TBL] [Abstract][Full Text] [Related]
32. Prostaglandin F2α FP receptor inhibitor reduces demyelination and motor dysfunction in a cuprizone-induced multiple sclerosis mouse model.
Iwasa K; Yamamoto S; Takahashi M; Suzuki S; Yagishita S; Awaji T; Maruyama K; Yoshikawa K
Prostaglandins Leukot Essent Fatty Acids; 2014 Nov; 91(5):175-82. PubMed ID: 25224839
[TBL] [Abstract][Full Text] [Related]
33. Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro.
Raijmakers R; Zendman AJ; Egberts WV; Vossenaar ER; Raats J; Soede-Huijbregts C; Rutjes FP; van Veelen PA; Drijfhout JW; Pruijn GJ
J Mol Biol; 2007 Apr; 367(4):1118-29. PubMed ID: 17303166
[TBL] [Abstract][Full Text] [Related]
34. Insights into the mechanism of streptonigrin-induced protein arginine deiminase inactivation.
Dreyton CJ; Anderson ED; Subramanian V; Boger DL; Thompson PR
Bioorg Med Chem; 2014 Feb; 22(4):1362-9. PubMed ID: 24440480
[TBL] [Abstract][Full Text] [Related]
35. Halogen Bonding Increases the Potency and Isozyme Selectivity of Protein Arginine Deiminase 1 Inhibitors.
Mondal S; Gong X; Zhang X; Salinger AJ; Zheng L; Sen S; Weerapana E; Zhang X; Thompson PR
Angew Chem Int Ed Engl; 2019 Sep; 58(36):12476-12480. PubMed ID: 31276611
[TBL] [Abstract][Full Text] [Related]
36. Developmental and age-related changes of peptidylarginine deiminase 2 in the mouse brain.
Shimada N; Handa S; Uchida Y; Fukuda M; Maruyama N; Asaga H; Choi EK; Lee J; Ishigami A
J Neurosci Res; 2010 Mar; 88(4):798-806. PubMed ID: 19830834
[TBL] [Abstract][Full Text] [Related]
37. Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods.
Khan N; Woodruff TM; Smith MT
Pharmacol Biochem Behav; 2014 Nov; 126():13-27. PubMed ID: 25223977
[TBL] [Abstract][Full Text] [Related]
38. Olesoxime accelerates myelination and promotes repair in models of demyelination.
Magalon K; Zimmer C; Cayre M; Khaldi J; Bourbon C; Robles I; Tardif G; Viola A; Pruss RM; Bordet T; Durbec P
Ann Neurol; 2012 Feb; 71(2):213-26. PubMed ID: 22367994
[TBL] [Abstract][Full Text] [Related]
39. Expression of peptidylarginine deiminase 4 in an alkali injury model of retinal gliosis.
Wizeman JW; Mohan R
Biochem Biophys Res Commun; 2017 May; 487(1):134-139. PubMed ID: 28400047
[TBL] [Abstract][Full Text] [Related]
40. TNF superfamily member TWEAK exacerbates inflammation and demyelination in the cuprizone-induced model.
Iocca HA; Plant SR; Wang Y; Runkel L; O'Connor BP; Lundsmith ET; Hahm K; van Deventer HW; Burkly LC; Ting JP
J Neuroimmunol; 2008 Feb; 194(1-2):97-106. PubMed ID: 18207576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
